Sionna Therapeutics (SION) Cash & Equivalents (2024 - 2026)
Quarterly results put Cash & Equivalents at $63.3 million for Q1 2026, down 23.42% from a year ago — trailing twelve months through Mar 2026 was $63.3 million (down 23.42% YoY), and the annual figure for FY2025 was $58.5 million, up 54.68%.
Sionna Therapeutics has reported Cash & Equivalents over the past 3 years, most recently at $63.3 million for Q1 2026.
- Cash & Equivalents reached $63.3 million in Q1 2026 per SION's latest filing, up from $58.5 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $82.8 million in Q1 2024 and bottomed at $35.7 million in Q3 2024.
- Median Cash & Equivalents over the past 3 years was $50.8 million (2025), compared with a mean of $55.2 million.
- The largest annual shift saw Cash & Equivalents skyrocketed 54.68% in 2025 before it dropped 23.42% in 2026.
- Over 3 years, Cash & Equivalents stood at $37.8 million in 2024, then soared by 54.68% to $58.5 million in 2025, then rose by 8.34% to $63.3 million in 2026.
- Business Quant data shows Cash & Equivalents for SION at $63.3 million in Q1 2026, $58.5 million in Q4 2025, and $50.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 63.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.32 Mn |
| Dec 31, 2025 | 58.45 Mn |
| Sep 30, 2025 | 50.83 Mn |
| Jun 30, 2025 | 40.99 Mn |
| Mar 31, 2025 | 82.70 Mn |
| Dec 31, 2024 | 37.79 Mn |
| Sep 30, 2024 | 35.75 Mn |
| Jun 30, 2024 | 44.02 Mn |
| Mar 31, 2024 | 82.75 Mn |